Unclassified

On November 26, 2022, the Second Suzhou International Forum on Ophthalmic Artificial Intelligence was held in Suzhou. The conference was jointly organized by the Medical Image Processing and Analysis Laboratory of Suzhou University, the National Clinical Research Center for Eye Diseases, and the China Life Science and Technology Industry Alliance. It was hosted by Suzhou Big Vision Medical Technology Co., Ltd. and co-organized by the Oriental Medical Device Industry Technology Innovation Center. The conference invited many well-known scholars in the field of

Recently, Big Vision, in collaboration with ophthalmology experts Director Peng Qing and Director Gao Peng from the Shanghai Tenth People’s Hospital, published a paper in the renowned journal Frontiers in Cell and Development Biology (impact factor: 6.081). This study verified the feasibility and effectiveness of Big Vision’s ophthalmic AI in community eye disease screening. Age-related macular degeneration (AMD), diabetic retinopathy (DR), high myopia, as well as macular diseases such as macular epiretinal membrane and macular hole are important factors causing vision

Recently, the list of units for Innovative Tasks for AI Medical Devices was announced. Big Vision  Medical Technology was selected as one of the units for intelligent diagnostic products based on its independently developed ophthalmic OCT image-assisted diagnostic software (MIAS-3000). In order to implement the important instructions and spirits of the state about promoting innovative tasks for AI medical devices, accelerate the deep integration development between AI technology and medical equipment, better serve and protect people’s health, on October 26, 2022,

The highly anticipated “8th Dry Eye Conference” arrived as scheduled on November 4-5, 2022 at the Rongxin Huayi Hotel in Haicang, Xiamen! The “Dry Eye Conference” has gone through eight years and has become a characteristic conference brand in the fields of domestic and foreign dry eye, ocular surface and tear, and traditional Chinese ophthalmology. Here, new concepts, new developments, and new technologies from both China and abroad collide and converge, receiving extensive recognition and attention from the industry. Big Vision was

The 2022 Annual Academic Conference of Guangxi Medical Association Ophthalmology and the New Progress in Children’s Eye and Visual Optics Learning Class in Guangxi were successfully held from November 3 to 5, 2022 at the Nanning Exhibition Shangri-La Hotel. The conference invited famous experts from inside and outside the region to give keynote speeches on various topics through academic lectures, speeches, and academic posters, bringing an enriching and exciting academic and product exchange feast to everyone.   Big Vision was invited to

Seven Years, New Horizon, New Journey and New Harvests Big Vision Medical Technology celebrates its 7th anniversary Over the past seven years, the team of partners has been continuously growing Seven years of ups and downs, Seven years of glorious chapters, We never rush and are never radical, We always uphold the original intention of the enterprise, And move forward in hard work and endeavor. On the occasion of the 7th anniversary of Big Vision Medical Technology We express our sincere gratitude to all employees and customers who have always cared

On September 30th, 2022, the Visual Screening Device BVS200 independently developed by Big Vision Medical Technology obtained the Medical Device Registration Certificate of the People’s Republic of China Class II Medical Devices issued by the Jiangxi Provincial Drug Administration. The successful acquisition of the Medical Device Registration Certificate for the Visual Screening Device BVS200 fully reflects the excellent independent research and development capabilities of Big Vision Medical Technology, and further enhances the company’s comprehensive market competitiveness. Big Vision Medical Technology will continue to innovate

Forge Ahead into a New Journey, Make Achievements in a New Era According to the decisions made at the State Council’s executive meeting on September 7th, it was decided to provide stage-based financial interest subsidies for equipment updates and upgrades in some fields, and increase credit support for social services, to promote consumer-driven growth. Subsequently, the National Health Commission issued a notice, intending to use financial interest-subsidized loans to update and upgrade medical equipment. Financial interest-subsidized loans are generally fully open

Today, the “2022 Ophthalmology Development New Engine Summit Forum and National Ophthalmic Medical Imaging New Progress Learning Class,” co-sponsored by the Eye Specialized Committee of the China Non-Public Medical Institutions Association, the District and County Study Group of the Shanghai Medical Association Eye Branch, the Jing’an District Medical Association of Shanghai, and Shanghai Jing’an District Shibei Hospital, was held as scheduled. The 2022 Ophthalmology Development New Engine Summit Forum. This conference adopts offline classes and online live streaming, inviting top

Recently, the China Association for Medical Devices Industry completed the selection of products for the eighth batch of excellent domestically produced medical devices, among which, the Big Vision Optical Coherence Tomography (OCT) BV1000 was listed as an honor and selected into the eighth batch of “Excellent Domestically Produced Medical Device Product Catalog”. Big Vision selected/listed The selection of the eighth batch of excellent domestically produced medical devices was organized by the China Association for Medical Devices Industry under the commission of the Planning, Development